Literature DB >> 3886790

Hormonal modulation of responses to thymus-independent and thymus-dependent antigens in autoimmune NZB/W mice.

J E Brick, D A Wilson, S E Walker.   

Abstract

Previous work suggested that gonadal steroids influence immunity through the thymus, but the mechanisms were unclear. To investigate the effects of these hormones on immune responses to T1 and TD antigens in autoimmune mice, we studied hybrid NZB/W mice and the nonautoimmune DBA/2 strain. Mice castrated at 14 days of age were implanted with Silastic capsules releasing, in adults, physiologic levels of E2 in males or Te in females. Sham-operated controls received empty capsules. Splenic PFC were quantified 4 to 5 days after challenge with the TI2 antigen TNP-Ficoll, the TI1 antigen TNP-LPS, or the TD antigen SRBC. Young castrated NZB/W males implanted with E2 had striking enhancement of IgM responses to TNP-Ficoll when compared to castrated Te-treated females and comparable sham-operated controls of both sexes. E2 also stimulated responses to TNP-LPS. In response to challenge with SRBC, young E2-treated NZB/W males had a consistent trend to increased IgM PFC, and the stimulatory effect of E2 on IgG plaques was variable. Physiologic doses of Te had no consistent effect on responses in young mice. In old female NZB/W mice, Te caused PFC response after immunization with TNP-Ficoll to resemble age-matched NZB/W males. As sham-operated NZB/W females grew older, PFC responses to SRBC fell. This age-related phenomenon was delayed, however, in female castrates implanted with Te. In contrast, Te clearly suppressed responses to TNP-LPS. Implantation of E2 did not alter responses to TNP-Ficoll, TNP-LPS, or SRBC in nonautoimmune DBA/2 males. This finding suggested that exogenous E2 given in physiologic doses did not influence immunologic responsiveness in a normal strain to the degree seen in hormone-sensitive NZB/W mice. It was concluded that E2 enhanced responses to a variety of exogenous antigens in autoimmune NZB/W mice. The most consistent E2-induced increase in PFC response was observed with TI antigens, suggesting that E2 exerted its effects on B cells or Ts.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3886790

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Androgens suppress antigen-specific T cell responses and IFN-γ production during intracranial LCMV infection.

Authors:  Adora A Lin; Sara E Wojciechowski; David A Hildeman
Journal:  J Neuroimmunol       Date:  2010-09-14       Impact factor: 3.478

Review 2.  Sex hormones, glucocorticoids and autoimmunity: facts and hypotheses.

Authors:  J A Da Silva
Journal:  Ann Rheum Dis       Date:  1995-01       Impact factor: 19.103

3.  Castration alters peripheral immune function in normal male mice.

Authors:  S M Viselli; S Stanziale; K Shults; W J Kovacs; N J Olsen
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

4.  Delay of postnatal maturation sensitizes the mouse prostate to testosterone-induced pronounced hyperplasia: protective role of estrogen receptor-beta.

Authors:  Saija Savolainen; Tomi Pakarainen; Ilpo Huhtaniemi; Matti Poutanen; Sari Mäkelä
Journal:  Am J Pathol       Date:  2007-07-19       Impact factor: 4.307

Review 5.  Influence of ovarian hormones on urogenital infection.

Authors:  C Sonnex
Journal:  Sex Transm Infect       Date:  1998-02       Impact factor: 3.519

6.  Sex hormones modulate the response of pulmonary perivascular inflammation to cyclophosphamide therapy in MRL/MpJ-lpr/lpr mice.

Authors:  W N McKenzie; E V Sunderrajan; J L Kavanaugh; S Braun; L Ansbacher; S E Walker
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

Review 7.  The influence of season, photoperiod, and pineal melatonin on immune function.

Authors:  R J Nelson; G E Demas; S L Klein; L J Kriegsfeld
Journal:  J Pineal Res       Date:  1995-11       Impact factor: 13.007

8.  Estrogen administration activates extrathymic T cell differentiation in the liver.

Authors:  R Okuyama; T Abo; S Seki; T Ohteki; K Sugiura; A Kusumi; K Kumagai
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.